Farallon Capital Management LLC Amarin Corp Plcuk Transaction History

Farallon Capital Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $2.39 Million - $4.13 Million	-500,000 Reduced 13.79%	3,125,000 $21.6 Million
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $2 Million - $10.8 Million	-500,000 Reduced 12.12%	3,625,000 $14.5 Million
Q4 2019 Feb 13, 2020	BUY	$13.94 - $24.12 $29.6 Million - $51.2 Million	2,124,400 Added 106.19%	4,125,000 $88.4 Million
Q3 2019 Nov 14, 2019	SELL	$13.89 - $23.16 $31.2 Million - $52.1 Million	-2,249,400 Reduced 52.93%	2,000,600 $30.3 Million
Q2 2019 Aug 14, 2019	BUY	$16.27 - $20.51 $16.3 Million - $20.5 Million	1,000,000 Added 30.77%	4,250,000 $82.4 Million
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $3.15 Million - $5.58 Million	-250,000 Reduced 7.14%	3,250,000 $67.5 Million
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $2.32 Million - $4.3 Million	187,300 Added 5.65%	3,500,000 $47.6 Million
Q3 2018 Nov 14, 2018	SELL	$2.45 - $16.27 $2.87 Million - $19.1 Million	-1,172,300 Reduced 26.14%	3,312,700 $53.9 Million
Q2 2018 Aug 14, 2018	SELL	$2.68 - $3.48 $201,000 - $261,000	-75,000 Reduced 1.64%	4,485,000 $13.9 Million
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $13.6 Million - $20.2 Million	4,560,000 New	4,560,000 $13.7 Million

181

69.6M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Farallon Capital Management LLC with notifications on news.